Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs17288270 | chr8:74271939 | C/A | 1.11E-16 | 171 | 25.4 | 26.57 | 3.17 | KM Plot |
PCPG | rs17297991 | chr10:131970634 | T/G | 0 | 177 | 25.6 | 24.47 | 3.17 | KM Plot |
PCPG | rs17303178 | chr12:12485351 | G/A | 2.1E-8 | 171 | 25.17 | 28.47 | 7.2 | KM Plot |
PCPG | rs17343556 | chr7:105151272 | C/T | 5.56E-5 | 177 | 20.17 | 29.43 | 2.28 | KM Plot |
PCPG | rs17345863 | chr16:71523261 | C/T | 0 | 177 | 24.52 | 29.02 | 3.17 | KM Plot |
PCPG | rs17347255 | chr16:71587225 | C/T | 0.000141 | 173 | 24.85 | 31.47 | 15.82 | KM Plot |
PCPG | rs1736196 | chr19:2868662 | G/A | 0.000389 | 170 | 25.67 | 16.97 | 116.37 | KM Plot |
PCPG | rs17363814 | chr19:4844633 | A/G | 3.01E-6 | 178 | 16.23 | 26.57 | 25.4 | KM Plot |
PCPG | rs1741738 | chr6:26401252 | A/G | 1.11E-16 | 174 | 24.7 | 30.25 | 3.17 | KM Plot |
PCPG | rs17456400 | chr10:69849664 | T/G | 0 | 172 | 25.77 | 21.45 | 2.28 | KM Plot |
PCPG | rs17457340 | chr20:10640042 | T/C | 0.000173 | 177 | 24.23 | 28.52 | 14.28 | KM Plot |
PCPG | rs1748335 | chr10:26932699 | C/G | 0.000146 | 178 | 26.27 | 22.63 | 24.53 | KM Plot |
PCPG | rs17508783 | chr11:43419910 | A/G | 0.000209 | 178 | 25.08 | 25.53 | 23.73 | KM Plot |
PCPG | rs17510931 | chr2:118697457 | C/A | 1.6E-5 | 178 | 25.17 | 30.93 | 11.65 | KM Plot |
PCPG | rs17528296 | chr2:118855807 | C/T | 2.32E-5 | 174 | 25 | 25.97 | 11.65 | KM Plot |